Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07429890 · ClinicalTrials.gov registry record
REVIVE Prospective Registry Cohort Study
A clinical trial, sponsored by University of California, Davis.
- Not yet
- Registry status
- 31
- Enrollment target
NCT07429890 is a clinical trial that has not yet begun recruiting, run by University of California, Davis. The registered enrollment target is 31 participants.
The verdict
NCT07429890 has not yet begun recruiting, sponsored by University of California, Davis.
- NOT YET RECRUITING
- Registry status
- 31 participants
- Enrollment target
Study Summary
The main purpose of this registry is to collect observational, long-term safety and effectiveness data in participants who have received iltamiocel as part of the blinded portion of the REVIVE clinical study.
Interventions
- OTHER Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2026-08-30 |
| Est. Completion | 2032-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07429890
The ClinicalTrials.gov registry entry for NCT07429890 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention. is the first listed.
NCT07429890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07429890 about?
NCT07429890 is a clinical study titled "REVIVE Prospective Registry Cohort Study". The main purpose of this registry is to collect observational, long-term safety and effectiveness data in participants who have received iltamiocel as part of the blinded portion of the REVIVE clinical study.
What is the current status of trial NCT07429890?
This trial is currently not yet recruiting. The enrollment target is 31 participants. The study started on 2026-08-30. Estimated completion is 2032-06-30.
What interventions are being tested in trial NCT07429890?
The interventions under investigation include: Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention. (OTHER).
Who is sponsoring clinical trial NCT07429890?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.